Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem
NCT ID: NCT01614028
Last Updated: 2013-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Viability of Short Stems in Total Hip Arthroplasty
NCT02577822
Anatomical Femoral Stem in Total Hip Arthroplasty
NCT04243980
A Randomized Study of Approaches in Total Hip Arthroplasty
NCT01613508
Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem
NCT01566916
Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
NCT00951145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total Hip Arthroplasty using Fitmore femoral stem
Total Hip Arthoplasty
Total Hip Arthroplasty using M/L Taper Femoral stem
Total Hip Arthoplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total Hip Arthoplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
* Patient has primary diagnosis of non-inflammatory degenerative joint disease.
* Patient is a candidate for primary cementless total hip replacement.
* Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
Exclusion Criteria
* Patient has an active or suspected infection at the time of device implantation.
* Patient is immunologically suppressed.
* Patient requires revision surgery of a previously implanted total hip replacement.
* Patient has a known sensitivity to device materials.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rothman Institute Orthopaedics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rothman Institute at AtlantiCare
Egg Harbor, New Jersey, United States
Rothman Institute at Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anne Marie Madden, CCRP
Role: primary
Tiffany Morrison, MS, CCRP
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JP2012-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.